SCHEMBL565789

SCHEMBL565789

COc1ccc(C(=O)O)cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 8/20 0.77
RARB P10826 8/20 0.77
RARG P13631 8/20 0.77
MEN1 O00255 3/20 0.77
KMT2A Q03164 3/20 0.77
LMNA P02545 2/20 0.77
NR1I2 O75469 1/20 0.77
PGR P06401 1/20 0.77
HSPD1 P10809 1/20 0.77
GOT1 P17174 1/20 0.77
GLRA1 P23415 1/20 0.77
BLM P54132 1/20 0.77
HSPE1 P61604 1/20 0.77
TDP1 Q9NUW8 1/20 0.77
HDAC11 Q96DB2 2/20 0.53
HDAC2 Q92769 1/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA4 P22748 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1082340 1.00 RARA (0.77) RARARARBRARGMEN1KMT2A
Hydrochloric Acid SCHEMBL9124255 0.99 RARA (0.76) RARARARBRARGMEN1KMT2A
SCHEMBL6364425 0.92 RARA (0.71) RARARARBRARGMEN1KMT2A
SCHEMBL8458512 0.91 RARB (0.81) RARARARBRARGMEN1KMT2A
SCHEMBL9124257 0.90 RARA (0.65) RARARARBRARGMEN1KMT2A
SCHEMBL14027627 0.89 RARB (0.82) RARARARBRARGMEN1KMT2A
SCHEMBL5078191 0.89 RARA (0.67) RARARARBRARGMEN1KMT2A
SCHEMBL5366339 0.89 RARA (0.63) RARARARBRARGMEN1KMT2A
SCHEMBL9493164 0.89 RARA (0.63) RARARARBRARGMEN1KMT2A
SCHEMBL566680 0.89 RARG (0.66) RARARARBRARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409728-B1 Bi-aromatic esters, process for their preparation and their use in human or animal medicine and in cosmetics CIRD GALDERMA (FR) 1995-03-01 EP claimed
EP-0409728-A2 Bi-aromatic esters, process for their preparation and their use in human or animal medicine and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1991-01-23 EP claimed
EP-2740721-B1 NOVEL BENZOIC ACID AMIDE COMPOUND AMOREPACIFIC CORP (KR) 2017-03-22 EP disclosed
US-9254251-B2 Benzoic acid amide compound AMOREPACIFIC CORPORATION (KR) 2016-02-09 US disclosed
US-9181182-B2 S1P receptors modulators AKAAL PHARMA PTY LTD (AU) 2015-11-10 US disclosed
US-20140234241-A1 NOVEL BENZOIC ACID AMIDE COMPOUND AMOREPACIFIC CORPORATION (KR) 2014-08-21 US disclosed
EP-2740721-A2 NOVEL BENZOIC ACID AMIDE COMPOUND Amorepacific Corporation (KR) 2014-06-11 EP disclosed
US-20120034270-A1 S1P Receptors Modulators AKAAL PHARMA PTY LTD (AU) 2012-02-09 US disclosed
EP-2344446-A1 S1P RECEPTORS MODULATORS Akaal Pharma Pty Ltd (AU) 2011-07-20 EP disclosed
WO-2010095041-A2 COMPOSITIONS, METHODS, AND KITS FOR TREATING INFLUENZA VIRAL INFECTIONS EXCRX (SINGAPORE) PTE.LTD. (SG) 2010-08-26 WO disclosed
WO-2010042998-A1 S1P RECEPTORS MODULATORS AKAAL PHARMA PTY LTD (AU) 2010-04-22 WO disclosed
US-5173289-A Skin disorders, antiinflammatory agents CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (C.I.R.D.) (FR) 1992-12-22 US disclosed
US-5059621-A Treatment of dermatologic ailments linked to keratinization disorder CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (C.I.R.D.) (FR) 1991-10-22 US disclosed
US-5015758-A Process for the preparation of 1-adamantane derivatives CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (CIRD) (FR) 1991-05-14 US disclosed
EP-0409728-A2 Bi-aromatic esters, process for their preparation and their use in human or animal medicine and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1991-01-23 EP disclosed
US-4927928-A SKIN DISORDERS, EYES, ANTITUMOR CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) 1990-05-22 US disclosed
US-4925658-A TREATMENT OF DERMATOLOGIC, RHEUMATIC, RESPIRATORY, OPHTHALMOLOGIC DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (CIRD) (FR) 1990-05-15 US disclosed
US-4920140-A Skin disorders CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) 1990-04-24 US disclosed
EP-0325540-A1 Aromatic esters and thioesters, process for their preparation and their use in human or animal therapeutics and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) 1989-07-26 EP disclosed
US-4740519-A Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. (FR) 1988-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234241-A1 NOVEL BENZOIC ACID AMIDE COMPOUND TYR, AADAC, CUTA RARA 148/4885RARB 216/4885RARG 185/4885
US-20120034270-A1 S1P Receptors Modulators S1PR1, S1PR5, S1PR3 RARA 4192/4885RARB 3838/4885RARG 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.